What is NMN?
NMN, short for nicotinamide mononucleotide, is a molecule the body uses as a direct building block for NAD+, a coenzyme central to energy production.
NMN is a NAD+ precursor, sitting one step from NAD+ in the pathway cells use to build it. It is most often set against nicotinamide riboside, a related precursor that enters the same chain slightly earlier. Both are studied for their effect on sirtuins and on the health of mitochondria, the parts of the cell that turn fuel into usable energy.
NMN tends to interest people thinking about healthy ageing rather than short-term performance. The catch is that much of the promising work has been done in animals, and it is not yet clear how well oral NMN raises NAD+ in human tissues. It also needs consistent daily use, since stopping tends to return levels to baseline.
If NAD+ support is your goal, you can view our NMN.
Frequently asked questions
How is it different from nicotinamide riboside?
Both are NAD+ precursors, but NMN sits one step closer to NAD+ in the building pathway. They also differ in how the body absorbs and transports them.
When is NMN the right choice?
It suits people focused on supporting NAD+ that declines with age, as part of a longer-term routine. It is a foundation ingredient rather than a stimulant.
When is NMN the wrong choice?
If you want same-day energy or a noticeable buzz, NMN will disappoint. Its case rests on gradual support, and human evidence is still developing.